Literature DB >> 11532053

The child of uncertain sex: 17 years of experience.

A E Al-Agha1, M J Thomsett, J A Batch.   

Abstract

OBJECTIVE: To review the common clinical presentations, investigations and final diagnosis of children presenting with genital ambiguity.
METHODOLOGY: Retrospective search of the Royal Children's Hospital, Brisbane, Australia, medical records and personal medical database of one of the authors (MJT) between 1982 and 1999.
RESULTS: Fifty-one children aged 0.1-14 (mean 3.9) years were identified. Twenty-two cases had a 46XX karyotype, and commonly presented with an enlarged phallus (77.2%), urogenital sinus (63.6%) and labioscrotal fold(s) (40.9%). Congenital adrenal hyperplasia (CAH) was the most common final diagnosis (72.7%). Twenty-nine cases of genital ambiguity had a 46XY karyotype and commonly presented with palpable gonad(s) (75.8%), undescended testes (51.7%), penoscrotal hypospadias (51.7%) and a small phallus (41.3%). Androgen insensitivity and gonadal dysgenesis were the commonest final diagnosis both occurring at a frequency of 17.2%.
CONCLUSIONS: The results emphasize the importance of CAH as the most common diagnosis in 46XX cases presenting with ambiguous genitalia. Those with 46XY had a wider range of diagnoses. Despite thorough investigation, 23.5% had no definite final diagnosis made.

Entities:  

Mesh:

Year:  2001        PMID: 11532053     DOI: 10.1046/j.1440-1754.2001.00669.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  10 in total

1.  Management of children with disorders of sex development: 20-year experience in southern Thailand.

Authors:  Somchit Jaruratanasirikul; Vorapun Engchaun
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

Review 2.  Current concepts in disorders of sexual development.

Authors:  Gönül Öçal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

3.  Etiological classification and clinical assessment of children and adolescents with disorders of sex development.

Authors:  Sema Erdoğan; Cengiz Kara; Ahmet Uçaktürk; Murat Aydın
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-08-06

4.  Classic congenital adrenal hyperplasia: A delayed presentation.

Authors:  Saima Aziz Siddiqui; Nargis Soomro; Ashraf Ganatra
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

5.  Clinical Spectrum of Disorders of Sex Development: A Cross-sectional Observational Study.

Authors:  Sheeraz A Dar; Mudasir Nazir; Roumissa Lone; Duri Sameen; Ikhlas Ahmad; Wasim A Wani; Bashir A Charoo
Journal:  Indian J Endocrinol Metab       Date:  2018 Nov-Dec

6.  Ambiguous genitalia: An overview of 7 years experience at the Children's Hospital & Institute of Child Health, Lahore, Pakistan.

Authors:  Jaida Manzoor; Sommayya Aftab; Muhammad Yaqoob
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

7.  Etiology and Clinical Presentation of Disorders of Sex Development in Kenyan Children and Adolescents.

Authors:  Prisca Amolo; Paul Laigong; Anjumanara Omar; Stenvert Drop
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

8.  Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD

Authors:  Neşe Akcan; Oya Uyguner; Firdevs Baş; Umut Altunoğlu; Güven Toksoy; Birsen Karaman; Şahin Avcı; Zehra Yavaş Abalı; Şükran Poyrazoğlu; Agharza Aghayev; Volkan Karaman; Rüveyde Bundak; Seher Başaran; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-02-09

9.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10

10.  Disorders of sex development: a study of 194 cases.

Authors:  R Walia; M Singla; K Vaiphei; S Kumar; A Bhansali
Journal:  Endocr Connect       Date:  2018-01-31       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.